Plasma endostatin and its association with new-onset acute kidney injury in critical care
Endostatin at ICU admission is an independent predictor of new-onset AKI and may improve early AKI risk assessment in the ICU. However, its predictive value for RRT and 30-day mortality appears limited. External validation and studies on its clinical utility are warranted.
Authors
- Hans Friberg (ORCID: https://orcid.org/0000-0002-5588-0098)
- Hazem Koozi (ORCID: https://orcid.org/0000-0002-5892-3524)
- Anders Larsson (ORCID: https://orcid.org/0000-0002-0702-8343)
- Martin Spångfors (ORCID: https://orcid.org/0000-0001-8754-899X)
- Attila Frigyesi (ORCID: https://orcid.org/0000-0002-0155-4828)
- Jonas Engström (ORCID: https://orcid.org/0000-0003-1421-3640)
Institutions
- Uppsala University (SE)
- Uppsala University Hospital (SE)
- Lund University (SE)
- Kristianstad University (SE)
- Skåne University Hospital (SE)
- Centralsjukhuset Kristianstad (SE)
Publication Details
- Journal
- Journal of Intensive Care
- Published
- 2025-09-02
- DOI
- https://doi.org/10.1186/s40560-025-00820-z
- Citations
- 1
- Primary Topic
- Acute Kidney Injury Research
- Type
- article
- Field-Weighted Citation Impact
- 1.43
Funders
- Crafoordska Stiftelsen
- Lunds Universitet
- Skånes universitetssjukhus
- Hans-Gabriel och Alice Trolle-Wachtmeisters stiftelse för medicinsk forskning